Breaking news Pfizer plunges over 4% as it scraps obesity pill trials Giugno 26, 2023 The shares of Pfizer Inc. tumbled more than 4% on Monday following the news the pharma giant decided to halt the development of its experimental obesity pill lotiglipron. Ahead of the session, Pfizer…
